MedGenome: Amit Kakar, Felix Olale

MedGenome, a global genomics-driven diagnostics and research services company with offices in Foster City, California and Bangalore, India, has appointed Amit Kakar as chairman of the board. Kakar takes over from Felix Olale, who concluded his two-year term as board chairman and will focus his efforts on leading the growth of MedGenome's US and North America business.

Kakar has served on the MedGenome board of directors since 2022 and is managing partner and head of Asia at Novo Holdings, a global life sciences investor wholly owned by the Novo Nordisk Foundation. He also serves on the boards of Doctor Anywhere, an omni-channel healthcare service provider; ESCO, a Singapore-based life science company; and Qure.ai, a health tech firm headquartered in India. Kakar served as head of healthcare investments at Avenue Capital for eight years, and previously worked at GE Healthcare for over 14 years, holding various senior positions in India, China, and the US. He was also head of M&A and business development at Everlife Asia in Singapore.